Cargando…
Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802507/ https://www.ncbi.nlm.nih.gov/pubmed/29167420 http://dx.doi.org/10.1038/s41408-017-0002-2 |
_version_ | 1783298532572135424 |
---|---|
author | Tsukune, Yutaka Sasaki, Makoto Odajima, Takeshi Sunami, Kazutaka Takei, Tomomi Moriuchi, Yukiyoshi Iino, Masaki Isoda, Atsushi Nakaya, Aya Muta, Tsuyoshi Miyake, Takaaki Miyazaki, Koji Shimizu, Takayuki Nakajima, Kei Igarashi, Aiko Nagafuji, Koji Kurihara, Taro Aoyama, Tomonori Sugimori, Hiroki Komatsu, Norio |
author_facet | Tsukune, Yutaka Sasaki, Makoto Odajima, Takeshi Sunami, Kazutaka Takei, Tomomi Moriuchi, Yukiyoshi Iino, Masaki Isoda, Atsushi Nakaya, Aya Muta, Tsuyoshi Miyake, Takaaki Miyazaki, Koji Shimizu, Takayuki Nakajima, Kei Igarashi, Aiko Nagafuji, Koji Kurihara, Taro Aoyama, Tomonori Sugimori, Hiroki Komatsu, Norio |
author_sort | Tsukune, Yutaka |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5802507 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-58025072018-02-08 Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan Tsukune, Yutaka Sasaki, Makoto Odajima, Takeshi Sunami, Kazutaka Takei, Tomomi Moriuchi, Yukiyoshi Iino, Masaki Isoda, Atsushi Nakaya, Aya Muta, Tsuyoshi Miyake, Takaaki Miyazaki, Koji Shimizu, Takayuki Nakajima, Kei Igarashi, Aiko Nagafuji, Koji Kurihara, Taro Aoyama, Tomonori Sugimori, Hiroki Komatsu, Norio Blood Cancer J Correspondence Nature Publishing Group UK 2017-11-23 /pmc/articles/PMC5802507/ /pubmed/29167420 http://dx.doi.org/10.1038/s41408-017-0002-2 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Correspondence Tsukune, Yutaka Sasaki, Makoto Odajima, Takeshi Sunami, Kazutaka Takei, Tomomi Moriuchi, Yukiyoshi Iino, Masaki Isoda, Atsushi Nakaya, Aya Muta, Tsuyoshi Miyake, Takaaki Miyazaki, Koji Shimizu, Takayuki Nakajima, Kei Igarashi, Aiko Nagafuji, Koji Kurihara, Taro Aoyama, Tomonori Sugimori, Hiroki Komatsu, Norio Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan |
title | Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan |
title_full | Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan |
title_fullStr | Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan |
title_full_unstemmed | Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan |
title_short | Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan |
title_sort | incidence and risk factors of hepatitis b virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in japan |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802507/ https://www.ncbi.nlm.nih.gov/pubmed/29167420 http://dx.doi.org/10.1038/s41408-017-0002-2 |
work_keys_str_mv | AT tsukuneyutaka incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan AT sasakimakoto incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan AT odajimatakeshi incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan AT sunamikazutaka incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan AT takeitomomi incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan AT moriuchiyukiyoshi incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan AT iinomasaki incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan AT isodaatsushi incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan AT nakayaaya incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan AT mutatsuyoshi incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan AT miyaketakaaki incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan AT miyazakikoji incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan AT shimizutakayuki incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan AT nakajimakei incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan AT igarashiaiko incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan AT nagafujikoji incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan AT kuriharataro incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan AT aoyamatomonori incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan AT sugimorihiroki incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan AT komatsunorio incidenceandriskfactorsofhepatitisbvirusreactivationinpatientswithmultiplemyelomainanerawithnovelagentsanationwideretrospectivestudyinjapan |